Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
1995-7-17
|
pubmed:abstractText |
The elongation factor Tu (EF-Tu) is a member of the GTP/GDP-binding proteins and interacts with various partners during the elongation cycle of protein biosynthesis thereby mediating the correct binding of amino-acylated transfer RNA (aa-tRNA) to the acceptor site (A-site) of the ribosome. After GTP hydrolysis EF-Tu is released in its GDP-bound state. In vivo, EF-Tu is post-translationally modified by phosphorylation. Here we report that the phosphorylation of EF-Tu by a ribosome associated kinase activity is drastically enhanced by EF-Ts. The antibiotic kirromycin, known to block EF-Tu function, inhibits the modification. This effect is specific, since kirromycin-resistant mutants do become phosphorylated in the presence of the antibiotic. On the other hand, phosphorylated wild-type EF-Tu does not bind kirromycin. Most interestingly, the phosphorylation of EF-Tu abolishes its ability to bind aa-tRNA. In the GTP conformation the site of modification is located at the interface between domains 1 and 3 and is involved in a strong interdomain hydrogen bond. Introduction of a charged phosphate group at this position will change the interaction between the domains, leading to an opening of the molecule reminiscent of the GDP conformation. A model for the function of EF-Tu phosphorylation in protein biosynthesis is presented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Elongation Factor Tu,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Elongation Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridones,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Transfer, Amino Acyl,
http://linkedlifedata.com/resource/pubmed/chemical/elongation factor Ts,
http://linkedlifedata.com/resource/pubmed/chemical/mocimycin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
270
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14541-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7782317-Anti-Bacterial Agents,
pubmed-meshheading:7782317-Computer Graphics,
pubmed-meshheading:7782317-Escherichia coli,
pubmed-meshheading:7782317-Models, Molecular,
pubmed-meshheading:7782317-Peptide Elongation Factor Tu,
pubmed-meshheading:7782317-Peptide Elongation Factors,
pubmed-meshheading:7782317-Phosphorylation,
pubmed-meshheading:7782317-Protein Conformation,
pubmed-meshheading:7782317-Protein Processing, Post-Translational,
pubmed-meshheading:7782317-Pyridones,
pubmed-meshheading:7782317-RNA, Transfer, Amino Acyl
|
pubmed:year |
1995
|
pubmed:articleTitle |
Phosphorylation of elongation factor Tu prevents ternary complex formation.
|
pubmed:affiliation |
Institut für Biochemie, Freie Universität Berlin, Dahlem, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|